Use of Postexposure Prophylaxis After Occupational Exposure to Zaire ebolavirus.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 27118786.
- Also identified by DOI 10.1093/cid/ciw256 and PMC identifier 4946014.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
From September 2014 to April 2015, 6 persons who had occupational exposures to Zaire ebolavirus in West Africa received investigational agent rVSV-ZEBOV or TKM-100802 for postexposure prophylaxis and were monitored in the United States. All patients experienced self-limited symptoms after postexposure prophylaxis; none developed Ebola virus disease.
Medical subject headings
- Ebolavirus
- Hemorrhagic Fever, Ebola
- Occupational Exposure